Display options
Share it on

Cells. 2014 Jun 11;3(2):616-26. doi: 10.3390/cells3020616.

Unique Responses are Observed in Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1 and TRPV1) Co-Expressing Cells.

Cells

Laura R Sadofsky, Koti T Sreekrishna, Yakang Lin, Renee Schinaman, Kate Gorka, Yogita Mantri, John Christian Haught, Thomas G Huggins, Robert J Isfort, Charles C Bascom, Alyn H Morice

Affiliations

  1. Cardiovascular and Respiratory Studies, The University of Hull, HU6 7RX, UK. [email protected].
  2. The Procter & Gamble Company, Mason, OH 45040, USA. [email protected].
  3. The Procter & Gamble Company, Mason, OH 45040, USA. [email protected].
  4. The Procter & Gamble Company, Mason, OH 45040, USA. [email protected].
  5. The Procter & Gamble Company, Mason, OH 45040, USA. [email protected].
  6. The Procter & Gamble Company, Mason, OH 45040, USA. [email protected].
  7. The Procter & Gamble Company, Mason, OH 45040, USA. [email protected].
  8. The Procter & Gamble Company, Mason, OH 45040, USA. [email protected].
  9. The Procter & Gamble Company, Mason, OH 45040, USA. [email protected].
  10. The Procter & Gamble Company, Mason, OH 45040, USA. [email protected].
  11. Cardiovascular and Respiratory Studies, The University of Hull, HU6 7RX, UK. [email protected].

PMID: 24921186 PMCID: PMC4092848 DOI: 10.3390/cells3020616

Abstract

Transient receptor potential (TRP) ankyrin 1 (TRPA1) and vanilloid 1 (TRPV1) receptors are implicated in modulation of cough and nociception. In vivo, TRPA1 and TRPV1 are often co-expressed in neurons and TRPA1V1 hetero-tetramer formation is noted in cells co-transfected with the respective expression plasmids. In order to understand the impact of TRP receptor interaction on activity, we created stable cell lines expressing the TRPA1, TRPV1 and co-expressing the TRPA1 and TRPV1 (TRPA1V1) receptors. Among the 600 compounds screened against these receptors, we observed a number of compounds that activated the TRPA1, TRPV1 and TRPA1V1 receptors; compounds that activated TRPA1 and TRPA1V1; compounds that activated TRPV1 and TRPA1V1; compounds in which TRPA1V1 response was modulated by either TRPA1 or TRPV1; and compounds that activated only TRPV1 or TRPA1 or TRPA1V1; and one compound that activated TRPA1 and TRPV1, but not TRPA1V1. These results suggest that co-expression of TRPA1 and TRPV1 receptors imparts unique activation profiles different from that of cells expressing only TRPA1 or TRPV1.

References

  1. Cell. 2006 Mar 24;124(6):1269-82 - PubMed
  2. Cell. 2003 Mar 21;112(6):819-29 - PubMed
  3. Neuroscience. 2010 Dec 29;171(4):1109-19 - PubMed
  4. J Biol Chem. 2001 Jul 27;276(30):28613-9 - PubMed
  5. Br J Pharmacol. 2012 Mar;165(6):1966-1977 - PubMed
  6. J Biol Chem. 2010 May 14;285(20):15167-15177 - PubMed
  7. J Neurosci. 2008 Jan 30;28(5):1064-75 - PubMed
  8. Am J Respir Crit Care Med. 2009 Dec 1;180(11):1042-7 - PubMed
  9. Nature. 2007 Feb 1;445(7127):541-5 - PubMed
  10. Exp Lung Res. 2005 Apr;31(3):295-306 - PubMed
  11. J Physiol. 2007 Aug 15;583(Pt 1):175-93 - PubMed
  12. Phytother Res. 2011 Nov;25(11):1666-70 - PubMed
  13. Exp Lung Res. 2008 Dec;34(10):681-93 - PubMed
  14. Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13525-30 - PubMed
  15. Biomol Ther (Seoul). 2012 Nov;20(6):550-5 - PubMed
  16. Neuron. 2004 Mar 25;41(6):849-57 - PubMed
  17. Curr Biol. 2011 Feb 22;21(4):316-21 - PubMed
  18. Nature. 1997 Oct 23;389(6653):816-24 - PubMed
  19. Eur J Pharmacol. 2001 Apr 6;417(1-2):51-8 - PubMed
  20. Pain. 2008 Apr;135(3):271-279 - PubMed
  21. Nature. 2004 Jan 15;427(6971):260-5 - PubMed

Publication Types